Access comprehensive drug regulatory information for India, including approval status, dates, and categories for over 15,000 drugs. Stay updated with the latest pharma news and track upcoming drug pipelines. Offers expert consulting services for specialized queries.
1.0.7
July 29, 2026
What's Improved Improved app performance and stability. Fixed reported bugs and resolved minor issues. Enhanced user interface for a smoother experience. Optimized loading speed and responsiveness. Improved overall reliability and security.
MorePharminho provides regulatory intelligence for the pharmaceutical industry in India. It allows users to check drug approval status, dates, categories, and access news and expert consulting services.
Pharminho's drug repository contains over 15,000 drugs, offering detailed regulatory profiles for each.
Pharminho provides the latest CDSCO and Pharma regulatory news, updated regularly, covering approvals, enforcement actions, and industry-shaping regulatory changes.
Yes, Pharminho offers expert consulting services for custom answers to specific queries, including global approval status and market research reports.
Pro membership unlocks deeper regulatory insights, such as strengths, compositions, indications, and official approval letters, and allows access to consulting services.
Pharminho is available on iPhone, iPad, and iPod, indicated by its age rating of 12+.
The latest version of Pharminho is 1.0.4, and it was last updated on July 22, 2026, suggesting regular updates to maintain data accuracy and add new features.
No, Pharminho does not contain advertisements, allowing for an uninterrupted user experience.
